Clinical trial reportJournal of immunology (Baltimore, Md. : 1950)Published
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of immunology (Baltimore, Md. : 1950)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasm Metastasis; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Immunotherapy; Adult; Aged; Middle Aged; Female; Antibodies, Monoclonal, Humanized; Triple Negative Breast Neoplasms; Immune Checkpoint Inhibitors
- PubMed ID
- 40338159
- Added to directory
- Source checked